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Abstract
Lineage-committed cells of many tissues exhibit substantial plasticity in contexts such as wound
healing and tumorigenesis, but the regulation of this process is not well understood. Here, we
identified the Hippo transducer WWTR1/TAZ in a screen of transcription factors able to prompt
lineage switching of mammary epithelial cells. Forced expression of TAZ in luminal cells induces
them to adopt basal characteristics, and depletion of TAZ in basal/myoepithelial cells leads to
luminal differentiation. In human and mouse tissues, TAZ is active only in basal cells and is
critical for basal cell maintenance during homeostasis. Accordingly, loss of TAZ affects mammary
gland development, leading to an imbalance of luminal and basal populations as well as branching
defects. Mechanistically, TAZ interacts with components of the SWI/SNF complex to modulate
lineage-specific gene expression. Collectively, these findings uncover a new role for Hippo
signaling in the determination of lineage identity through recruitment of chromatin remodeling
complexes.
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Introduction
Cellular differentiation can no longer be considered a permanent or unidirectional process,
given the mounting examples where cells are able to change their identity in response to a
variety of physiologic, pathologic, or experimental stimuli (Galliot and Ghila, 2010). The
strongest evidence for such phenomena comes from recent lineage-tracing studies in diverse
settings such as the lung (Tata et al., 2013), pancreas (Zhou et al., 2008), and hair follicle
(Rompolas et al., 2013), in which the fates of differentiated cells and their progeny were
definitively mapped with genetic markers. A common theme in these examples is that in
response to tissue injury, ex vivo culture, or oncogenic transformation, lineage-committed
cells and/or their progeny exhibit “lineage infidelity” and adopt alternate cell fates. The
context-dependent nature of such plasticity strongly implies regulation; however, in most
cases, the important players have not been identified.
Cells of the mammary epithelium also exhibit context-dependent plasticity. They are
comprised of two major cell populations, luminal and basal/myoepithelial (ME), which are
distinguishable in terms of their anatomic location, function, and ontogeny (Visvader, 2009).
Luminal cells line the lumens of ducts and alveoli and are responsible for milk production,
while basal/ME cells contact the basement membrane and contract to pump milk through the
ducts. Both populations originate from a common KRT14-expressing mammary stem cell
(MaSC) during embryonic development (Spike et al., 2012; Tsai et al., 1996; Visvader and
Lindeman, 2006) but the existence and significance of MaSCs in adult tissues remains
contentious. Genetic lineage tracing studies from different groups have produced
irreconcilable data that either demonstrate or refute the presence of MaSCs in adult tissues
(Rios et al., 2014; (van Keymeulen et al. 2011, Van Amerongen et al., 2012). On the other
hand, regardless of the marker used for in vivo labeling, no lineage tracing studies have
identified bipotent luminal cells in situ, indicating that all luminal cells appear to be lineage-
restricted during normal development (van Keymeulen et al., 2011).
However, basal and luminal lineage barriers clearly break down in certain non-physiologic
settings. It is well known that murine basal cells have the capacity to generate an entire
functional mammary epithelial tree when transplanted into the cleared fat pat of a recipient
mouse (Kordon and Smith, 1998; Shackleton et al., 2006), even when it can be demonstrated
by lineage tracing that the transplanted cells do not exhibit bipotent differentiation potential
during normal development (Van Amerongen et al., 2012). While luminal cells generally
lack this potential, ex vivo culture of luminal human mammary epithelial cells can induce
them to adopt stem-like or bipotent features (Keller et al., 2012; Chaffer et al., 2011;
Pechoux et al., 1999). In addition, luminal cells are the likely cells-of-origin for basal-like
breast tumors, suggesting that they also acquire plasticity during tumorigenesis (Keller et al.,
2012; Proia et al. 2011, Molyneux et al., 2010).
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What allows lineage-committed MECs to become bi-potent in these settings? Transcription
factors (TFs) are likely candidates, since they are master orchestrators of the gene
expression programs that define specific differentiation states. Thus, we sought to determine
whether committed luminal cells could be induced to acquire features of basal/ME cells by
the activity of a single transcription factor. We developed a gain-of-function screen in which
TFs were expressed in luminal epithelial cells, and identified candidates able to induce a
basal/ME-like phenotype. Using this approach, we identified the Hippo transducer
WWTR1/TAZ as a regulator of the basal/ME progenitor phenotype in the mammary gland.
We demonstrate that modulation of TAZ is sufficient to effect changes in differentiation
state, and that it directly associates with SWI/SNF chromatin-remodeling complexes to both
repress the expression of luminal-specific genes and activate basal-specific genes.
Results
Identification of TAZ in a gain-of-function screen of epithelial lineage plasticity
Previously, we reported that highly pure populations of EpCAM+ luminal and CD10+
basal/ME cells can be isolated from the bulk population of cells derived from discarded
breast reduction tissues (Keller et al., 2012). Cells isolated this way exhibit different colony-
forming potential in vitro. CD10+ basal cells readily form adherent colonies on tissue
culture substrates and rapidly acquire a bi-potent differentiation state, expressing both
luminal and basal cytokeratins. In contrast, EpCAM+ luminal cells rarely attach to plastic
substrates, reflecting the minimal contact between luminal cells and the extracellular matrix
(ECM) in vivo. Instead, they float in suspension as spherical colonies and retain their
luminal characteristics. Thus, we endeavored to identify potential regulators of epithelial
plasticity by screening for TFs that would prompt luminal cells to adopt an adherent
phenotype.
A pooled lentiviral cDNA library consisting of ∼1000 human TFs was generated for this
purpose (Table S1). We then employed FACS to isolate EpCAM+ luminal cells from freshly
dissociated reduction mammoplasty tissue, and transduced the cells either with the pooled
lentiviral library or with an empty-vector control lentivirus (Figure 1A). Infected cells were
seeded under adherent conditions and allowed to form colonies, while the non-adherent cells
were discarded. To identify the factors promoting luminal cell adherence, transduced TF
cDNAs were recovered from genomic DNA by PCR, followed by high-throughput
sequencing of the PCR amplicons. An enrichment score for each TF was calculated by
dividing the number of reads for each TF in the screened cells by that of transduced (but
unscreened) control cells.
Using this approach we identified 52 TFs with greater than two-fold enrichment in the
screened cells relative to control cells (Figures 1B, 1C). We noted that six TF hits (HOXA5,
HOXA9, ID1, ID2, ID3, and SNAI1) have been previously implicated in either basal/ME
epithelial differentiation or EMT, and four additional hits (BTBD1, LIMS1, KLHDC5,
HOXC4) have also been recently reported to be preferentially expressed in human
mammary basal/stem cells (MaSC), a testament to the validity of the approach (Lim et al.,
2010) (Figure 1C). Indeed, gene set enrichment analysis of the screen “hits” revealed
enrichment in previously published gene expression profiles of sorted basal/ME cells,
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further demonstrating that adherent colony formation is indeed a valid surrogate marker for
the basal/ME cell phenotype (Fig 1D).
Among the remaining 42 novel hits we identified WWTR1, a transducer of Hippo signaling
(commonly referred to as TAZ, 7.38-fold enriched). TAZ and its paralog YAP are
transcriptional co-activators that lack a DNA-binding domain, but regulate self-renewal and
differentiation of stem cells in many cell tissue types via direct interaction with sequence-
specific DNA-binding proteins, such as the TEAD family of transcription factors (Pan,
2010). We were intrigued by previous studies which demonstrated that TAZ overexpression
can trigger proliferation and induce EMT-like changes in epithelial cells (Lei et al., 2008).
Basal/ME cells share many features with mesenchymal cells, such as a lack of apicobasal
polarity, limited intercellular contacts, and high vimentin expression (Prat et al., 2013;
Sarrió et al., 2008) . We therefore hypothesized that TAZ might also be able to impart such
properties to luminal MECs.
To validate the ability of TAZ to promote adherent colony formation, freshly dissociated
MECs were FACS-sorted and transduced with lentivirus containing TAZ cDNA alone.
Consistent with the primary screen, TAZ overexpression led to a five- to ten-fold increase in
the number of adherent colonies observed after plating of freshly dissociated EpCAM+
luminal cells (Figure 1E). Furthermore, when TAZ was overexpressed in unsorted cells, we
observed a measurable increase in the formation of bipotent KRT14+/KRT18+ colonies as
well as an increase in K14+ myoepithelial colonies (Figure 1F) compared with control cells.
We also seeded the same cells in 3D collagen/matrigel cultures. We have previously shown
that when grown in collagen/matrigel, CD10+ basal/ME cells preferentially formed
elongated ductal structures or flat colonies, whereas EpCAM+ luminal cells formed round
acinar structures (Keller et al., 2012). Forced TAZ expression led to a decrease in round
colonies with a corresponding increase in flat colonies (Figure 1G); thus, TAZ-infected cells
behaved similarly to primary basal cells. We conclude that in primary MECs, TAZ
expression is sufficient for committed luminal cells to adopt features of basal/ME cells.
TAZ controls mammary epithelial differentiation state
Based on the above findings, we hypothesized that TAZ might act to promote linage
switching by repressing luminal-specific gene expression and/or activating basal/ME-
specific gene expression, resulting in basal/ME differentiation. To test this, we utilized
MCF10A and MCF10F cell lines, which are non-tumorigenic, spontaneously immortalized
mammary cell lines derived from the same donor. MCF10F and MCF10A cells were derived
from disease-free breast tissue; MCF10F cells were generated from free-floating cells in the
primary culture and are heterogeneous, containing stable subpopulations of luminal-like and
basal-like cells (Figure 2D). In contrast, MCF10A cells were derived from the adherent cells
and homogeneously exhibit a predominantly basal-like phenotype with low expression of
luminal markers compared to MCF10F (Soule et al., 1990 and Figure S1A, red bars).
Examination of endogenous TAZ expression levels in the MCF10 system revealed that
basal-like MCF10A cells expressed higher levels of TAZ relative to the more luminal-like
MCF10F cells (Figure S1A, gray bar). Therefore, to examine how TAZ may promote
lineage switching, we expressed TAZ cDNA in MCF10F cells or inhibited TAZ in MCF10A
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cells using shRNAs, and asked whether TAZ modulation could influence differentiation
state.
When TAZ was overexpressed in MCF10F cells, they adopted a distinct elongated
morphology, forming looser colonies and exhibiting a striking lack of cell-cell contacts
(Figures 2A). When grown in 3D collagen cultures, MCF10F-TAZ cells generated
significant fewer round colonies than control cells, and exhibited a trend toward increased
ductal morphogenesis, similar to primary MECs (Figure 2B). Furthermore, lineage-specific
marker and gene expression analysis of MCF10F-TAZ cells also revealed changes in their
differentiation potential. We noticed that MCF10F cells were heterogeneous. Luminal and
basal subpopulations of MCF10F cells could be resolved by flow cytometry using a
combination of EpCAM and CD44 expression (Figure 2C and Figure S1B), and FACS-
purified cells from these populations also expressed additional luminal- and basal-specific
lineage markers (Figure S1C) and exhibited distinct morphologies (Figure S1D).
Interestingly, TAZ overexpression in MCF10F cells caused an expansion of the basal
subpopulation relative to the luminal subpopulation, suggesting that TAZ may enhance the
conversion of luminal MCF10F cells into basal MCF10F cells (Figure 2D), and replacing
wild-type TAZ cDNA with a constitutively active mutant TAZ (S89A) dramatically
amplified this effect.
The shift toward a basal immunophenotype was also associated with reduced expression of
luminal markers such as MUC1, CDH1, EpCAM, and GATA3 (Figure 2E). Expression of the
TAZ-S89A mutant also led to similar gene expression changes (Figure S1E). Although
luminal epithelial markers such as EpCAM and CDH1 were significantly reduced in
MCF10F-TAZ cells, the expression of cytokeratins remained high, suggesting that the cells
had not undergone EMT. However, because mRNA levels of basal markers did not increase
significantly (Figure 2E), the EpCAM-/CD44+ cells that expanded in response to TAZ most
likely represent an intermediate state, and additional factors may be required along with
TAZ to fully specify basal differentiation.
As TAZ expression was sufficient to repress the luminal phenotype, we next wondered
whether TAZ was also required in basal MCF10A cells to maintain their differentiation
state. Therefore, we used lentivirus to deliver shRNAs against TAZ to MCF10A cultures,
depleting TAZ protein levels to ∼25% that of control cells (shScram vs shTAZ, Figure 2F-
K).
MCF10A-shTAZ cultures grew more slowly than shScram cells (Figure 2H) and generated
fewer mammospheres under non-adherent culture conditions (Figure 2I) suggesting a
decrease in proliferative potential and/or progenitor activity. Intriguingly, a significant
proportion of shTAZ cells detached from the plastic substrate and floated as nonadherent
cells in the growth medium (Figure 2F, arrows), reminiscent of the phenotype of primary
luminal breast epithelial cells. When grown at low density in a 50% mixture of collagen I
and Matrigel, the propensity of shTAZ cells to generate ductal structures was markedly
reduced; adherent shTAZ cells formed 80% fewer ductal colonies than control cells (Figure
2J). However, floating shTAZ cells did not expand in number in either 2D or 3D adherent
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conditions or as non-adherent mammospheres, suggesting a near-complete lack of
proliferative potential in these cells (not shown).
We performed gene expression analysis of various lineage markers of basal and luminal
differentiation on adherent and floating shTAZ cells. We used global gene expression data
from Lim et al. (2010) to identify marker genes associated with basal/MaSC, luminal
progenitor, or mature luminal differentiation state and analyzed the expression of these
genes in adherent vs. floating cells lacking TAZ using qPCR as well as the nCounter
platform (Figure 2K and Figure S1F-G). Both populations of shTAZ cells (floating and
adherent) showed a strong decrease in proliferation-associated gene expression compared
with control cells, consistent with the decrease in proliferative capacity of shTAZ cells
(Figure S1F, right). Adherent shTAZ cells displayed an increase in several markers of
luminal differentiation, such as CD24, MUC1 and CLDN4, and in particular displayed up-
regulation of markers of luminal progenitor cells (e.g. KRT6B, CD14, and ALDH1A3, Figure
S1G). Paradoxically, these cells also exhibited upregulation of KRT14, although KRT14 is
also expressed in a subset of luminal cells in the human mammary gland (Santagata et al.,
2014). Non-adherent shTAZ cells showed very strong expression of the same genes and also
expressed more mature luminal transcripts including ESR1 and PGR, which are typically
only expressed in a subset of mature non-proliferating luminal cells. We confirmed the
expression of ERα protein in floating shTAZ cells by Western blot (Figure S1H).
Because YAP and TAZ often exhibit functional redundancy, we also asked whether YAP is
also able to repress luminal differentiation. Unlike TAZ, YAP knockdown did not lead to
changes in cellular morphology or to loss of adhesion (Figure S1I). While YAP knockdown
in MCF10A cells led to repression of the well-known YAP/TAZ target gene CTGF, these
cells did not exhibit the same transcriptional changes in lineage markers as shTAZ cells and
in fact YAP knockdown appeared to result in opposite changes in many lineage markers
(Figure S1J). Therefore, repression of luminal differentiation is a unique function of TAZ.
Collectively, the data presented in Figure 2 suggest that TAZ can dynamically modulate
differentiation state in MECs. It is both sufficient to induce repression of lineage-specific
genes in luminal cells and required to maintain their repression in basal cells; hence, luminal
cells transition to a basal cell fate when TAZ is overexpressed, and basal cells undergo
luminal differentiation when TAZ is depleted.
Hippo signaling restricts TAZ to basal/ME cells
To determine whether TAZ functions in a lineage-specific manner in basal cells in vivo, we
examined the distribution of TAZ, its upstream regulators, and its transcriptional targets in
the mammary epithelium.
TAZ and its paralog YAP are regulated by the Hippo pathway (Zhao et al., 2011). In
response to Hippo signaling, TAZ is phosphorylated by LATS1/2 kinases, resulting in its
inactivation by either cytoplasmic retention, and/or ubiquitin-mediated destruction by the β-
TRCP complex. Therefore, to examine whether the nuclear localization of TAZ in basal
cells was associated with differences in Hippo signaling, purified EpCAM+ luminal and
CD10+ basal/ME cells were isolated from breast tissues using immunomagnetic beads
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(Figure 3A-B), and the level of TAZ and phospho-LATS1 were assessed by Western
blotting (Figure 3C).
Interestingly, strong activation of the Hippo pathway was detected in luminal cells as
evidenced by a high level of phospho-LATS1 expression in this population (Figure 3C). Yet
surprisingly, total protein levels of TAZ were not different in luminal cells vs. basal cells,
nor were TAZ mRNA levels significantly different between the two subpopulations (Figure
S2A and S2B). However, immunostaining of normal breast tissues with an antibody reactive
to both YAP and TAZ revealed a clear difference in the localization of YAP/TAZ (Figure
3D). Nuclear YAP/TAZ expression was restricted to basal/ME cells in terminal ductal-
lobular units (TDLUs), while luminal cells exhibited diffuse cytoplasmic localization of
YAP and TAZ in lobules and only occasional nuclear staining in larger-diameter ducts
(Figure 3F). Co-immunofluorescence staining for TAZ and KRT14 confirmed that TAZ was
frequently expressed in the nuclei of basal cells in a punctate pattern (Figure 3E).
We next asked whether TAZ expression was correlated with target gene activation. Two
canonical YAP/TAZ targets, CTGF and ANKRD1, were more highly expressed in basal
cells, although for CTGF the change did not reach statistical significance (Figure 3G). To
more broadly analyze YAP/TAZ-dependent transcription in basal and luminal cells, we used
publicly available gene expression data to generate a consensus signature of YAP/TAZ
transcriptional targets (Cordenonsi et al., 2011; Zhang et al., 2009; Zhang et al., 2008), and
tested the enrichment of the YAP/TAZ signature in previously published gene expression
profiles from the various mammary epithelial subpopulations (Lim et al., 2010; Raouf et al.,
2008; Shehata et al., 2012). As expected, the YAP/TAZ signature was significantly enriched
in the basal/MaSC subpopulation of both human and mouse mammary epithelia, while
luminal cells lacked enrichment of the TAZ signature (Figure 3H). Similar results were
obtained when we queried multiple, independent gene expression datasets for enrichment of
YAP/TAZ targets in the mammary epithelial subpopulations, testifying to the robustness of
the association between YAP/TAZ signaling and the basal/MaSC differentiation state
(Figure S2C-E). Thus, we conclude that TAZ is transcriptionally active only in basal cells in
human and mouse mammary tissues, exhibiting a spatial distribution consistent with a role
in regulation of lineage commitment.
TAZ is necessary for maintenance of the basal/ME lineage in vivo
The restricted expression pattern of TAZ in mouse and human tissues prompted us to ask
whether TAZ loss also affects lineage commitment in vivo. We therefore examined the
mammary glands of TAZ mutant mice (Wwtr1lacZ/lacZ) mice, in which exon 2 of Taz/Wwtr1
was replaced with a lacZ-stop reporter cassette (Tian et al., 2007). As previously reported,
Wwtr1lacZ/lacZ mice were viable but were born at sub-Mendelian ratios, with only ∼20% of
the expected numbers born from heterozygous crosses, and also exhibited a high perinatal
mortality rate (Figure S3A-B). TAZ mRNA was not detectable in the mammary glands of
Wwtr1lacZ animals by qPCR (not shown).
We performed whole-mount staining of mammary glands of nulliparous Wwrt1+/+,
Wwtr1+/lacZ mice, and Wwtr1lacZ/lacZ mice at various developmental stages including
pubescent (5 and 8 weeks old), as well as post-pubertal virgin (16 weeks old), to evaluate
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gross epithelial structure. In pubescent 5 and 8 week old mice, when the primordial
mammary tree is undergoing branching morphogenesis and invading into the fat pad, we did
not observe any differences between wild-type, heterozygous, or homozygous Wwtr1lacZ
glands (Figures S3C-E). Heterozygous and homozygous eight-week-old mice had a similar
number of terminal end buds, which invaded into the fat pad at a similar rate and gave rise to
a similar number of primary branches. However, post-pubertal 16 week-old Wwtr1+/lacZ and
Wwtr1lacZ/lacZ mice exhibited a significant reduction in the number and complexity of
tertiary side branching, with homozygotes displaying a more serious defect (Figures 4A and
4B). Histological analysis also revealed an overall reduction in the cross-sectional area of
the fat pad occupied by epithelium in Wwtr1+/lacZ and Wwtr1lacZ/lacZ mammary glands,
consistent with a general decrease in mammary gland cellularity and branching complexity
(Figure 4C).
Existing ducts and lobules in 16-week old Wwtr1lacZ mammary glands were
morphologically normal and contained a single layer of luminal and basal/ME cells (Figure
S3F). However, we observed that the density of nuclei in the basal/ME layer of
Wwtr1lacZ/lacZ ducts was noticeably sparser than in wild-type epithelia. To directly visualize
luminal and basal cells in situ, paraffin-embedded cross-sections of Wwtr1lacZ mammary
glands were co-stained with antibodies against EpCAM and alpha-smooth muscle actin
(SMA) and analyzed by immunofluorescence microscopy (Figures 4D-E). Wild-type,
heterozygous and homozygous Wwtr1lacZ ducts all displayed restricted expression of
EpCAM and SMA to the luminal and basal layers, respectively. However, the proportion of
SMA+ nuclei was dramatically reduced in Wwtr1-deficient epithelia, indicating a reduced
number of myoepithelial cells (Figure 4E). A modest decease in the number of basal/ME
cells was also observed in heterozygous animals. To further confirm this observation, we
analyzed freshly dissociated MECs from 16-week-old mice of all three genotypes using flow
cytometry for additional lineage-specific markers. Analysis of Wwtr1+/lacZ and
Wwtr1lacZ/lacZ MECs revealed an abnormal balance of Lin-CD49flowCD24high luminal cells
vs. Lin-CD49fhigh/CD24+ basal/ME cells, compared with age-matched wild-type mice
(Figures 4F and 4G). While wild-type epithelia contained roughly equal proportions of basal
and luminal cells, TAZ-deficient mammary glands harbored between two and five luminal
cells per basal cell, depending on the individual. As with the morphologic defects, there was
no difference in the ratio of basal and luminal cells during puberty (Figures S3G-H), again
suggesting TAZ is likely dispensable in the mammary gland at earlier developmental stages.
Cells in the mammary gland occasionally proliferate, which maintains the pool of epithelial
cells during homeostasis (Clarke, 2003). Given the pro-proliferative effects of TAZ in basal
MCF10A cells, we asked whether branching defects and altered subpopulation sizes in
Wwtr1lacZ mammary glands might simply explained by a proliferative imbalance between
the two lineages. However, surprisingly, after accounting for the reduced cellularity of
Wwtr1lacZ epithelia, there was no statistically significant difference in either the total
number of Ki67-positive proliferating cells vs. wild-type glands, or in the number of Ki67+
basal vs. luminal cells (Figure 4H). Therefore, it is unlikely that the observed lineage
imbalance in Wwtr1lacZ mice is due to a relative reduction of proliferative capacity in basal
cells or an increased rate of proliferation in luminal cells. We therefore wondered whether a
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loss or exhaustion of basally-oriented progenitor cells might instead underlie the phenotype
of Wwtr1-deficient mice. To evaluate progenitor activity, we subjected MECs isolated from
16-week old mice to an in vitro colony-forming assay. Wwtr1+/lacZ and Wwtr1lacZ/lacZ
MECs formed fewer KRT14+ colonies than wild-type cells, although in the case of the
heterozygotes, the difference did not reach statistical significance (Figure 4I). Collectively,
these data suggest that either Wwtr1lacZ mice lack sufficient basal progenitor cells to
maintain the lineage, or alternatively, that these cells sometimes produce luminal progeny.
SWI/SNF chromatin-remodeling complexes mediate the function of TAZ
We next sought to identify the mechanism by which TAZ influences cell fate and progenitor
activity in MECs. TAZ lacks a DNA-binding domain, but is capable of activating gene
expression by binding to other transcription factors such as TEADs and SMADs via
conserved protein-protein interaction domains (Sudol et al., 1995, Chen and Sudol, 1995).
However, very little is known about the mechanism by which TAZ binding leads to
transcriptional activation. To identify binding partners of TAZ that may participate in
regulation of MEC lineage commitment, we performed co-immunoprecipitation of FLAG-
tagged TAZ followed by mass spectrometry (IP/MS). Using this approach, we identified 102
high-confidence binding partners, including many of the known YAP/TAZ interactants such
as angiomotin (AMOT), 14-3-3 proteins, and many components of the apical junction/
polarity complex (Table S2). Of particular interest among the set of interacting proteins
identified by IP/MS were several components of the SWI/SNF chromatin-remodeling
complex, including the core subunits BAF155, BAF170, SNF5, and the catalytic ATPase
component, which can include either BRG1 or BRM, but not both (Figure 5A). SWI/SNF is
a set of evolutionarily conserved, multi-protein complexes capable of destabilizing the
interaction between DNA and nucleosomes in an ATP-dependent manner, leading to
nucleosome sliding or ejection and modification of higher-order chromatin structure (Müller
and Leutz, 2001; Wang et al., 1996). By affecting the state of chromatin at promoter regions,
SWI/SNF complexes can affect transcription factor accessibility and either repress or
activate transcription.
We confirmed the presence of a protein-protein interaction between endogenous TAZ and
the SWI/SNF catalytic subunit BRG1 in MCF10A cells by co-IP (Figure 5B). Upon
inspection of the peptide sequences of various SWI/SNF subunits, we found that multiple
SWI/SNF components contain one or more L/P-P-X-Y motifs, a binding site for the WW
domain of YAP and TAZ (Figure S4). Indeed, deletion of the WW domain of TAZ
abolished the interaction with BRG1 or BRM, suggesting a direct and specific interaction
between the WW domain of TAZ and at least one of the PPXY-containing SWI/SNF
subunits (Figure 5C and 5D). Interestingly, the PPXY motifs were conserved in vertebrates
but generally not in lower eukaryotes, suggesting that the TAZ-SWI/SNF interaction may be
a relatively recent evolutionary innovation (Figure S4).
We hypothesized that SWI/SNF complexes might mediate the function of TAZ to regulate
transcription and lineage commitment in MECs. As the nucleosome-remodeling function of
SWI/SNF complexes requires the presence of the ATPase subunit (Phelan et al., 1999), we
focused on modulating BRG1 and BRM levels in MECs. We used lentivirus to stably knock
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down either BRG1 or BRM in MCF10F cells and asked whether BRG1 depletion could
recapitulate the features of TAZ loss (Figure 5E).
Depletion of BRG1 did not affect expression of CTGF or ANKRD1, suggesting that BRG1 is
dispensable for transcription of TAZ target genes. On the other hand, BRM knockdown led
to a substantial decrease in CTGF and ANKRD1 mRNA levels (Figure 5F), despite
compensatory upregulation of BRG1 (Figure 5E). Furthermore, stable TAZ overexpression
and subsequent BRM/BRG1 knockdown using lentivirus demonstrated that BRM, but not
BRG1 depletion could reverse the TAZ-mediated expansion of basal CD44high/EpCAMlow
cells in the MCF10F cell line; upon BRM knockdown, the relative sizes of the luminal and
basal subpopulations of MCF10F-TAZ cells reverted to those of the lacZ control cell line
(Figure 5G and 5H). Similarly BRM, but not BRG1 knockdown could rescue the activation
of basal-specific genes CD44 and VIM by TAZ in MCF10F cells (Figure 5I). Finally,
analysis of the gene expression data from Lim et al. (2010) revealed that the pattern of BRM
mRNA expression in mammary epithelial subsets mirrored the expression of TAZ and its
target genes, being more highly expressed in the basal/MaSC subpopulation than in luminal
cells, which is consistent with a functional interaction between TAZ and BRM in vivo
(Figure 5J). On the other hand, BRG1 expression showed no statistical differences between
epithelial subsets, consistent with its inability to affect transcription of TAZ targets.
To determine whether TAZ could directly recruit BRG1/BRM to target genes, we performed
chromatin immunoprecipitation (ChIP) in MCF10A cells. We observed enrichment of BRM,
but not BRG1 at the CTGF promoter, a bona fide direct target of TAZ/TEAD (Figure 5K).
Furthermore, while overexpression of wild-type TAZ in MCF10A increased BRM
enrichment two-fold at the CTGF gene, the ΔWW mutant lacked this capacity. Instead, it
repressed enrichment of BRM below background levels, suggesting it could out-compete
endogenous TAZ for CTGF binding sites.
Taken together, these data demonstrate that BRM recruited by TAZ to regulate target gene
expression, and that TAZ requires BRM to repress luminal differentiation in mammary
epithelial cells. Although TAZ retains the ability to bind to BRG1 in MCF10A cells (Figure
5B), we were not able to identify a functional consequence of this interaction in the context
of MEC differentiation.
TAZ is amplified in basal-like breast cancer
Lastly, we asked whether TAZ might also influence breast tumor phenotype. Although the
majority of breast cancers originate from the transformation of luminal cells, the resulting
tumors can exhibit features of either luminal or basal differentiation at the histological and
molecular level (Keller et al., 2012; Prat and Perou, 2011). Interestingly, analysis of data
from The Cancer Genome Atlas (TCGA, Koboldt et al., 2012) revealed that 44% of basal-
like breast tumors exhibited some degree of TAZ copy number amplification, compared to
only 10 and 20% of luminal A and luminal B tumors, respectively (Figure 6A).
Concordantly, TAZ mRNA expression was much higher in basal-like tumors than in luminal
tumors from the TCGA dataset (Figure 6B). Furthermore, TAZ expression was negatively
correlated with the protein level of key luminal biomarkers such as GATA3, estrogen
receptor, and androgen receptor (False Discovery Rate [FDR[= 0%), and positively
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associated with protein levels of basal biomarkers (FDR = 0%), as measured by reverse-
phase protein arrays (Figure 6C). TAZ protein levels were also much higher in basal-like
breast cancer cell lines than in luminal-like cell lines (Figure 6D). Importantly, high TAZ
expression predicted poor survival in patients with basal-like tumors, but not in other
molecular subtypes, in accordance with the known oncogenic role of TAZ (Figure 6E).
Collectively and in light of the role of TAZ in lineage commitment, these data suggest that
high expression of TAZ may bias breast tumors toward a basal-like phenotype and promote
disease progression.
Discussion
Our initial goal was to identify novel regulators of mammary epithelial cell fate in a manner
that was both biologically relevant and human-oriented. We employed an innovative
screening approach designed to exploit a key functional distinction between basal and
luminal epithelial cells – namely, their ability to grow as adherent colonies on a plastic
substrate. We posit that a similar approach in other systems can complement the use of
murine genetic screens in the search for regulators of human development, as mouse models
do not always faithfully recapitulate human biology. However, the use of primary cells
derived from human tissue is critical, as it is well known that many cells, including MECs
do not maintain their identity after extended culture in vitro.
Our findings broadly imply that cellular differentiation states may be dynamically regulated
in normal cells and tissues via the activation or inactivation of specific transcriptional
factors. Lineage-tracing studies have definitively demonstrated the restricted nature of the
luminal lineage of the mammary gland during homeostasis (Van Keymeulen et al., 2011;
Van Amerongen et al., 2012; Rios et al., 2014). However, it is clear that luminal cell fate
decisions are not permanent, and can be reversed following in vitro culture or tumorigenesis.
The most striking finding of our study is the demonstration that modulation of a single
factor, TAZ, is capable on its own of dictating the differentiation state of mammary
epithelial cells – allowing luminal cells to adopt basal/ME features when overexpressed, or
inducing basal/ME cells to acquire luminal characteristics when depleted. In other words,
TAZ acts as molecular switch regulating luminal and basal phenotypes, and toggling of the
switch is sufficient to alter differentiation state.
Our results also imply that Hippo signaling plays an important role in regulating lineage
dynamics in the mammary gland through modulation of YAP/TAZ subcellular localization.
Hippo signaling appears to be active only in luminal cells, restricting TAZ to the cytoplasm,
while in basal cells YAP and TAZ can freely influence transcription of target genes. The
upstream regulation of Hippo signaling is an area of intensive research, but it is clear that
cell-cell junctions and polarity signals are strong negative regulators of YAP/TAZ and that
apical junction-associated signaling molecules such as angiomotin (AMOT) regulate the
Hippo core kinases (Chen et al., 2010; Grusche et al., 2010). In the mammary gland, only
luminal cells are polarized and exhibit extensive cell-cell contacts, suggesting a scenario
where TAZ is continuously kept in check by Hippo signaling in cells that maintain luminal
features, i.e. those cells that express adherens/tight junction molecules and maintain
apicobasal polarity. Intriguingly, these very same features are invariably lost in contexts
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where luminal-to-basal plasticity is seen, for example in cancer and ex vivo culture. We
propose that such a mechanism might underlie the lineage-restriction of luminal cells
observed in normal homeostasis, and when perturbed may result in lineage infidelity.
The lineage imbalances that result when TAZ is lost in vivo during development may also
reflect an essential role of TAZ in maintaining the lineage fidelity of basal cells. However,
given the current controversy regarding the existence of bipotent stem cells in the mammary
gland within the basal layer, this finding must be cautiously interpreted. On the one hand,
TAZ loss in unipotent basal progenitors may promote their trans-diffferentiation toward a
luminal cell fate. Alternatively, TAZ loss in bipotent MaSCs (assuming their presence in
adult tissues) may bias these cells to differentiate along the luminal lineage at an
inappropriately high rate. In both scenarios, the consequence would be a loss of basal
progenitors and an expansion of the luminal cell compartment similar to that seen in TAZ-
null mice. As the cellular hierarchy of the mammary epithelium is further resolved, it should
be possible to define which of these alternatives reflects the precise role of TAZ in MEC
lineage commitment.
We also demonstrated a tissue-level requirement for TAZ during development, being
required for epithelial side branching in adult virgin glands. As basal/ME cells are essential
for initiating side branching (Ewald et al., 2008; Gudjonsson et al., 2005), this defect likely
reflects the decreased proportion of basal cells in TAZ-null glands. Interestingly, TAZ was
seemingly dispensible for ductal invasion throughout the course of pubertal development.
This result suggests a functional or molecular distinction between progenitor cells that are
active during puberty versus in the adult virgin epithelium. Such a notion is supported by a
recent lineage tracing study demonstrating that Wnt-responsive progenitor cells contribute
variably to the luminal and basal lineages depending on the developmental stage when the
cells are genetically labeled (Van Amerongen et al. 2012). Specifically, prepubescent and
pubescent Wnt-responsive cells contribute to ductal invasion during puberty and are
unipotent, while individual Wnt-response cells in adult virgin glands drive alveologenesis
and may have the potential to generate both luminal and basal cells during pregnancy and
lactation. Given that TAZ mediates Wnt signaling (Azzolin et al. 2012, Rosenbluh et al.
2012), the functional differences between Wnt-responsive progenitors may underlie the
stage-specific requirement for TAZ in mammary gland development. However, additional
studies will be needed to more completely and precisely define the role of TAZ in mammary
gland development, including an investigation of the role of TAZ during pregnancy and
lactation.
A significant finding of our study is the notion that TAZ depends on chromatin-remodeling
factors to effect changes in differentiation state. We showed that the SWI/SNF complex
directly interacts with TAZ and is essential in mediating TAZ function. Our results expand
upon recent work in Drosophila demonstrating that Brahma (Brm) interacts with Yki/Sd
(the fly homologs of YAP/TAZ and TEADs, respectively) and regulates expression of
Yki/Sd targets in the fly midgut (Jin et al., 2013; Oh et al., 2013). Our results also imply a
functional distinction between BRG1 and BRM, in that only BRM could be recruited by
TAZ to regulate target genes. Both BRG1 and BRM retain the ability to bind to TAZ
through their PPXY motifs; therefore, we speculate that the lack of redundancy between
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BRM and BRG1 may result from binding to distinct sets of cofactors or other transcription
factors that provide specificity for particular promoter sequences. It is worth nothing that,
while BRG1 does not seem to be important for TAZ-mediated transcription in MECs, we
cannot rule out the possibility that it might regulate TAZ target genes in other cell types.
Finally, the finding that TAZ is associated with basal-like breast cancer is relevant to the
understanding of breast cancer heterogeneity, since basal and luminal molecular subtypes of
breast cancer share many features with their normal counterparts (Prat et al., 2013). The
Hippo pathway is dysregulated or inactivated in many human cancers, including breast
cancer (Pan, 2010); TAZ itself promotes proliferation and migration of breast cancer cells,
and has recently been linked to the cancer stem cell (CSC) phenotype and EMT in breast
cancer cell lines (Cordenonsi et al., 2011). We found that TAZ is particularly highly
expressed in basal and/or triple-negative breast cancers, reflecting its expression in normal
epithelia (Figure 6), and our results suggest that the high expression of TAZ in basal-like
tumors likely results from copy-number amplification. The finding that TAZ is amplified in
basal tumors and is also a prognostic marker strongly implies that TAZ may act as an
oncogenic driver specifically in basal-like tumors. The previously unrecognized role of TAZ
in lineage commitment, however, prompts the more profound question of whether genetic
amplification of TAZ is actually deterministic of the basal-like tumor phenotype. This
notion, if true, would have sweeping implications for our understanding of the histogenesis
of breast cancer subtypes.
Experimental Procedures
Cell Lines and Tissue Culture
Disease-free reduction mammoplasty specimens were obtained from Tufts Medical Center
in compliance with institutional and federal guidelines. Primary human MECs were isolated
from fresh tissues as described previously (see Keller et al., 2012 and Extended
Experimental Procedures). For all assays involving primary human MECs, cells were
cultured in mammary epithelial growth medium (MEGM, Lonza). MCF10A and MCF10F
cells were obtained from American Type Culture Collection (ATCC) and cultured according
to ATCC's recommended methods. For additional details see Extended Experimental
Procedures.
Isolation of HMEC Subpopulations
For the initial TF screen, EpCAM+ luminal cells were FACS-purified using an Influx Cell
Sorter (BD) after staining primary MECs with APC-conjugated EpCAM antibody (BD
#347200, 10 μl per million cells sorted). For analysis of Hippo signaling and TAZ
expression in basal and luminal MEC subpopulations, primary MECs were sorted using
immunomagnetic beads conjugated to anti-CD10 antibody (clone SS2/36, Santa Cruz) or
anti-EpCAM antibody (clone VU-ID9, AbD Serotec), as described previously (Keller et al.,
2012). Briefly, antibodies were first conjugated to CELLection pan-mouse IgG
immunomagnetic beads (Life Technologies), followed by sequential incubation with
primary HMEC, as depicted in Figure 3A, to generate three sorted fractions. Bound cells
were released from the beads following incubation with DNase (50 ug/ml, Roche).
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Lentivirus Production and Lentiviral DNA Constructs
Packaging of replication-defective lentivirus for infection has been previously described
(Keller et al. 2012). Protocols for lentivirus production and generation of stable cell lines are
detailed in Extended Experimental Procedures. Wild-type TAZ-FLAG and mutant TAZ-
FLAG constructs were obtained from Addgene (deposited by Jeff Wrana) and were cloned
into the pLenti 6.2/V5 DEST vector using the Gateway system (Life Technologies). shRNA
constructs were obtained from Sigma's MISSION RNAi library. A complete list of all
expression and shRNA vectors used to generate stable cell lines can be found in Extended
Experimental Procedures.
2D and 3D Colony Forming Assays
For adherent colony forming assays involving primary human and mouse MECs, 40,000
cells were seeded into 6-well plates, propagated for 10 days, fixed in 10% neutral buffered
formalin, and stained with either 0.1% crystal violet or KRT14 and KRT18 antibodies (see
Immunostaining) to visualize and quantify colonies. For mammosphere assays, 10,000
primary MECs or 5,000 MCF10A cells were seeded in 6-well ultra-low attachment tissue
culture plates (Corning) and propagated for five days. The entire 2 ml culture was then
diluted in a 3:2 mixture of Isoton II (Beckman Coulter) and glycerol, and analyzed using a
Multisizer 3 cytometer (Beckman Coulter). All particles meeting the 30-μm-diameter cutoff
were considered to be mammospheres. For 3D collagen assays, 10,000 primary HMECs or
1,000 MCF10A/MCF10F cells were overlayed on 4-well chamber slides (BD Falcon) coated
with 1 mg/ml type I collagen (Millipore, pH 7.0) and supplemented with 2% Matrigel (BD
Biosciences), solubilized in the growth medium. Cultures were allowed to propagate for 14
days, followed by microscopic analysis of the colony morphologies.
Quantitative RT-PCR and Nanostring nCounter Analysis
For all qPCR experiments, total RNA was extracted using the RNeasy Mini Kit (Qiagen).
cDNA was prepared from 1 ug of total RNA with the iScript kit (BioRad) according to the
manufacturer's instructions. qPCR was performed using SYBR Green Supermix (BioRad)
on a CFX96 Real-time Thermal Cycler (BioRad). Threshold cycle numbers were converted
to relative gene expression values using the 2-ΔΔCt method. Primer sequences, as well as
additional information regarding nCounter gene expression analysis, are available in
Extended Experimental Procedures.
Flow Cytometry
For analysis of adherent cell lines, cells were harvested by trypsinization, resuspended at
106/ml in PBS with 1% calf serum, and stained for 15 minutes at room temperature with the
appropriate antibodies at the appropriate dilutions. For flow cytometry of mouse MECs, the
bilateral 3rd, 4th, and 5th mammary glands were harvested, minced with scissors, digested in
collagenase, hyaluronidase, and trypsin to yield a single cell suspension, and stained as
above. Mouse MECs were additionally stained with PE-conjugated anti-TER119, anti-
CD31, and anti-CD45 antibodies (“Lin” stain), to allow for gating of Lin+ cells. All analytic
flow cytometry was carried out on a FACScalibur (BD), while sorting of EpCAM/CD44
subpopulations of MCF10F cells was performed on a MoFlo cell sorter (Beckman Coulter).
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Flow cytometry data was analyzed using FlowJo software. For a complete list of specific
antibodies and dilutions used in flow cytometry, see Extended Experimental Procedures.
Animals
All experiments involving animal subjects were carried out with the approval of the Tufts
University IACUC. 129S-Wwtr1tm1Benj mice were obtained from Jackson Laboratories
(Stock Number 011120, the mutant allele is referred to as Wwtr1lacZ in the text). Mice were
maintained on the 129S background for all studies by heterozygous crosses. For whole
mount analyses of mammary glands, the 4th mammary gland was dissected and fixed
overnight in 10% neutral buffered formalin, followed by 1-3 days of staining in 0.2%
carmine aluminum dye (Sigma). Glands were subsequently dehydrated in graded ethanols,
cleared by 1-3 days incubation in xylenes, and transferred to glycerol for long-term storage.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• TAZ controls differentiation state in mammary epithelial cell lines
• Loss of TAZ in mice leads to branching defects and loss of the basal/ME
population
• SWI/SNF complexes bind to TAZ and mediate its effects on transcription
• TAZ is overexpressed and amplified in basal-like breast cancer and predicts
survival
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Figure 1. Screen for transcription factors involved in MEC lineage commitment
A, Schematic of the screening approach used to identify novel regulators of MEC fate. B
and C, a list and dot plot representing the 46 identified TFs enriched greater than the two-
fold cutoff (indicated by the dotted line in C). Enrichment scores were calculated as a fold
increase over transduced but unscreened control cells (“pre-screen”). D, Box-and-whisker
plot showing enrichment scores of the complete set of screen hits in gene expression profiles
from purified mammary epithelial subsets as reported by Lim et al. (2010). E, MECs were
isolated and sorted as in A, transduced with lentivirus containing TAZ cDNA, and subjected
to a colony-forming assay. F, Unsorted MECs were transduced with TAZ cDNA and
subjected to a colony-forming assay as in E. The colonies were co-immunostained with
KRT14 (brown) and KRT18 (purple) to evaluate differentiation state (depicted in the
representative images on the left). G, TAZ-transduced MECs were plated on 1 mg/ml
collagen gels for colony formation and the colony types were quantified (classified as
ductal, round/acinar, or flat as indicated in the representative images). In all panels, error
bars represent the SEM. Significance values were computed by Student's t-test; a single
Skibinski et al. Page 20
Cell Rep. Author manuscript; available in PMC 2014 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
asterisk represent a significance level of p < 0.05, double asterisks indicate p < 0.01. All
colony-forming assays were performed using cells isolated from at least three tissue donors.
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Figure 2. TAZ controls MEC differentiation state
A-F, TAZ cDNA or lacZ cDNA was expressed in MCF10F cells using lentiviral vectors (N
= 3 experiments). A, Representative image of control MCF10F cells and MCF10F-TAZ
cells. B, 3D colony formation in MCF10F-TAZ cells. C, Flow cytometry of MCF10F cells
resolves EpCAMhigh/CD44low luminal-like and EpCAMlow/-/CD44high basal-like
subpopulations. D, The relative proportion of luminal and basal cells in MCF10F-TAZ was
quantified by the gating strategy indicated in C. S89A is a Hippo-refractory mutant form of
TAZ. E, mRNA expression of known TAZ target genes (dark grey bars), luminal markers
(red bars) and basal/ME markers (blue bars) in MCF10F-TAZ cells. Values are represented
as a log2 fold-change over LacZ control cells. F-K, TAZ was depleted in MCF10A cells
using shRNAs (N = 6 experiments). F, TAZ depletion caused many cells to become non-
adherent and detach from the substrate (arrows). G, TAZ protein levels following
transduction with shRNA constructs. H, Growth kinetics of MCF10A-shTAZ over 7 days. I,
Mammospheres (> 30 μm diameter) formed by MCF10A-shTAZ cells. J, 3D morphogenesis
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assay after MCF10A-shTAZ cells were seeded on collagen gels as in C. K, qRT-PCR
analysis of gene expression in MCF10A cells following TAZ knockdown. Gene expression
values are represented as a log2 fold change over the control cell line. In all panels, error
bars represent the SEM, a single asterisk indicates p < 0.05 and a double asterisk represents
p < 0.01 as determined by Student's t-test (pairwise against the control cell line). See also
Figure S1.
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Figure 3. Lineage-specific Hippo signaling and TAZ expression in breast tissues
A, Schematic of sorting strategy used to purify luminal and basal subsets from breast
reductions tissues using EpCAM and CD10 immunomagnetic beads. B, qRT-PCR analysis
of CD10 and EpCAM expression following sorting demonstrating enrichment of the
appropriate marker in the basal vs. luminal sorted cells (N = 4 tissue donors). C,
Representative Western blot analysis of phospho-LATS1, total LATS1, and TAZ protein
levels in purified luminal and basal cells. D, Low and high-power images of formalin fixed,
paraffin-embedded human breast tissue specimens immunostained with an antibody reactive
against both YAP and TAZ, demonstrating nuclear TAZ expression in basal cells. E, Co-
immunofluorescence staining with YAP/TAZ and KRT14, a marker of basal cells, showing
punctate nuclear for YAP/TAZ in K14+ cells vs. cytoplasmic staining in K14- cells (white
arrows). F, Quantitation of the percent of cells with nuclear YAP/TAZ expression in large-
diameter ducts vs. TDLUs. G, mRNA expression of TAZ targets CTGF and ANKRD1 in
sorted subpopulations. H, Enrichment analysis of the TAZ target gene signature in
microarray datasets of purified mouse and human MEC subpopulations. In all panels, error
bars represent the SEM, a single asterisk indicates p < 0.05 and double asterisks represents p
< 0.01 as determined by Student's t-test. See also Figure S2.
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Figure 4. Developmental defects and lineage imbalance in Taz/Wwtr1-deficient mice
A, Whole-mount images and B, quantification of branching complexity in mammary glands
from post-pubertal 16-week old Wwtr1lacZ mice (N = 6 per genotype). C, Quantification of
the average percentage of cross-sectional gland area occupied by epithelium in 16-week old
mice. D, Co-immunostaining of epithelia from 16-week old mice for EpCAM (red) and
SMA (green) revealed a reduced number of SMA+ cell bodies in Wwtr1-deficient glands
(arrows in bottom panels, N = 4 per genotype). E, Ratio of luminal to basal cells as
identified by staining in D. F-G, MECs were isolated as a single-cell suspension and
analyzed by flow cytometry. Representative biaxial plots (F) and mean proportions (G) of
Lin-CD24high/CD49low luminal and Lin-CD24+/CD49high basal cells within Wwtr1-deficient
epithelia are shown (N = 6 per genotype). H, Quantitation of Ki67-positive cells in 16-week
old mouse mammary tissues. I, Colony formation when MECs from 16-week old mice were
plated at clonal density on plastic substrates (N = 3). In all panels, error bars represent SEM,
a single asterisk indicates p < 0.05 and double asterisks represents p < 0.01 as determined by
Student's t-test (pairwise against wild-type). See also Figure S3.
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Figure 5. Chromatin-remodeling complexes mediate the function of TAZ
A, Schematic of canonical SWI/SNF subunits (left) with a list of the components identified
by TAZ-FLAG co-IP/mass spectrometry (right). B, Co-immunoprecipitation of endogenous
TAZ and BRG1, one of the two SWI/SNF ATPases, in nuclear lysates from MCF10A cells.
C-D, FLAG immunoprecipitation of either wild-type TAZ, or a deletion mutant lacking the
WW domain,n in 293T cells. E, Western blot demonstrating BRM or BRG1 depletion in
MCF10F cells using lentiviral shRNA vectors. F, qRT-PCR showing the expression of TAZ
targets CTGF and ANKRD1 upon BRM/BRG1 knockdown. G-I, TAZ cDNA was stably
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expressed in MCF10F cells, followed by stable knockdown of BRM or BRG1. G, The
luminal-like and basal-like MCF10F subpopulations were assessed by flow cytometry and
are quantified in H. I, The expression of basal markers VIM and CD44 was also assessed in
MCF10F-TAZ cells with or without BRM or BRG1 knockdown. J, Mean-centered gene
expression of BRM or BRG1 in mammary epithelial subsets as reported by Lim et al.
(2010). K, ChIP analysis of BRM and BRG1 at the CTGF promoter or RPL30 exon 3 in
MCF10A cells. Data are expressed as a fold enrichment over the IgG negative control. In all
panels, error bars indicate SEM, a single asterisk indicates p < 0.05 and a double asterisk
represents p < 0.01 as determined by Student's t-test. See also Figure S4.
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Figure 6. TAZ is associated with basal-like breast cancer
A, Analysis of TCGA data reveals that TAZ copy number is amplified in 44% of basal-like
breast tumors (either low- or high-level amplification). B, TAZ gene expression is highest in
basal-like tumors (error bars indicate SEM). C, Correlation between TAZ gene expression
and the protein expression of various biomarkers in TCGA dataset (Pearson's R statistic is
shown). D, Western blot showing TAZ protein levels in various breast cancer cell lines and
normal human MECs. E, Kaplan-Meier curves showing relapse-free survival probability of
patients with high or low TAZ gene expression in various breast cancer subtypes (log-rank
p-values are shown).
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